These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 17540213

  • 1. Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Sugioka K, Hozumi T, Takemoto Y, Ehara S, Ogawa K, Iwata S, Oe H, Matsumura Y, Otsuka R, Yoshiyama M, Yoshikawa J.
    Am Heart J; 2007 Jun; 153(6):1080.e1-6. PubMed ID: 17540213
    [Abstract] [Full Text] [Related]

  • 2. The effect of carvedilol therapy on coronary flow reserve in patients with idiopathic dilated cardiomyopathy.
    Calişkan M, Ciftçi O, Güllü H, Müderrisoğlu H.
    Turk Kardiyol Dern Ars; 2008 Jun; 36(4):247-52. PubMed ID: 18765968
    [Abstract] [Full Text] [Related]

  • 3. [The effect of carvedilol on coronary flow reserve in patients with dilated cardiomyopathy].
    Fan Y, Lin JH, Dong G, Zhu J, Yin F, Yang SS.
    Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):217-9. PubMed ID: 20450653
    [Abstract] [Full Text] [Related]

  • 4. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
    Naya M, Tsukamoto T, Morita K, Katoh C, Nishijima K, Komatsu H, Yamada S, Kuge Y, Tamaki N, Tsutsui H.
    J Nucl Med; 2009 Feb; 50(2):220-5. PubMed ID: 19164238
    [Abstract] [Full Text] [Related]

  • 5. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
    Paraskevaidis I, Farmakis D, Parissis JT, Dodouras T, Filippatos G, Tsiapras D, Kremastinos DT.
    J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050
    [Abstract] [Full Text] [Related]

  • 6. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment.
    Kawai K, Hata K, Takaoka H, Kawai H, Yokoyama M.
    Am Heart J; 2001 Jun; 141(6):925-32. PubMed ID: 11376305
    [Abstract] [Full Text] [Related]

  • 7. Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.
    Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Tange S, Suzuki T, Kurabayashi M.
    J Nucl Med; 2004 Nov; 45(11):1878-84. PubMed ID: 15534058
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of beta-blockers on left ventricular dyssynchrony and reverse remodeling in idiopathic dilated cardiomyopathy: A randomized trial of carvedilol and metoprolol.
    Kaya MG, Sarli B, Akpek M, Kaya EG, Yarlioglues M, Topsakal R, Lam YY.
    Cardiol J; 2014 Nov; 21(4):434-41. PubMed ID: 24142686
    [Abstract] [Full Text] [Related]

  • 9. Characterization of coronary flow reserve and left ventricular remodeling in a mouse model of chronic aortic regurgitation with carvedilol intervention.
    Wang X, Wu J, Zhu D, You J, Zou Y, Qian J, Ge J.
    J Ultrasound Med; 2015 Mar; 34(3):483-93. PubMed ID: 25715369
    [Abstract] [Full Text] [Related]

  • 10. Prognostic role of coronary flow reserve for left ventricular functional improvement after cardiac resynchronization therapy in patients with dilated cardiomyopathy.
    Djordjevic Dikic A, Nikcevic G, Raspopovic S, Jovanovic V, Tesic M, Beleslin B, Stepanovic J, Giga V, Milasinovic G.
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1344-9. PubMed ID: 25053732
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of carvedilol to abolish myocardial postsystolic shortening in patients with idiopathic dilated cardiomyopathy.
    Ito T, Kawanishi Y, Futai R, Terasaki F, Kitaura Y.
    Am J Cardiol; 2009 Dec 01; 104(11):1568-73. PubMed ID: 19932794
    [Abstract] [Full Text] [Related]

  • 12. Acute effect of esmolol intravenously on coronary microcirculation in patients with idiopathic dilated cardiomyopathy.
    Skalidis EI, Hamilos MI, Chlouverakis G, Kochiadakis GE, Parthenakis FI, Vardas PE.
    Am J Cardiol; 2007 Oct 15; 100(8):1299-302. PubMed ID: 17920374
    [Abstract] [Full Text] [Related]

  • 13. An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy.
    Rahko PS.
    Echocardiography; 2005 Aug 15; 22(7):547-54. PubMed ID: 16060890
    [Abstract] [Full Text] [Related]

  • 14. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E, Kurum T.
    Can J Cardiol; 2005 Mar 15; 21(4):344-8. PubMed ID: 15838561
    [Abstract] [Full Text] [Related]

  • 15. Early recovery of impaired coronary flow reserve by carvedilol therapy in patients with idiopathic dilated cardiomyopathy: a serial transthoracic Doppler echocardiographic study.
    Sugioka K, Hozumi T, Takemoto Y, Ujino K, Matsumura Y, Watanabe H, Fujimoto K, Yoshiyama M, Yoshikawa J.
    J Am Coll Cardiol; 2005 Jan 18; 45(2):318-9. PubMed ID: 15653035
    [No Abstract] [Full Text] [Related]

  • 16. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Seghatol FF, Shah DJ, Diluzio S, Bello D, Johnson MR, Cotts WG, O'Donohue JA, Bonow RO, Gheorghiade M, Rigolin VH.
    Am J Cardiol; 2004 Apr 01; 93(7):854-9. PubMed ID: 15050488
    [Abstract] [Full Text] [Related]

  • 17. Peripheral endothelial function may predict the effectiveness of beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Xie X, Wu B, Chen Y, Li W, Hu X, Chen J.
    Int J Cardiol; 2016 Oct 15; 221():128-33. PubMed ID: 27400309
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
    Di Lenarda A, Sabbadini G, Salvatore L, Sinagra G, Mestroni L, Pinamonti B, Gregori D, Ciani F, Muzzi A, Klugmann S, Camerini F.
    J Am Coll Cardiol; 1999 Jun 15; 33(7):1926-34. PubMed ID: 10362195
    [Abstract] [Full Text] [Related]

  • 19. Gated myocardial SPECT to predict response to beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Fukuchi K, Yasumura Y, Kiso K, Hayashida K, Miyatake K, Ishida Y.
    J Nucl Med; 2004 Apr 15; 45(4):527-31. PubMed ID: 15073245
    [Abstract] [Full Text] [Related]

  • 20. Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy.
    Neglia D, De Maria R, Masi S, Gallopin M, Pisani P, Pardini S, Gavazzi A, L'abbate A, Parodi O.
    Heart; 2007 Jul 15; 93(7):808-13. PubMed ID: 17237134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.